Agostinelli, Laura

Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis

Svegliati‐Baroni, G., Saccomanno, S., Rychlicki, C., Agostinelli, L., De Minicis, S., Candelaresi, C., Faraci, G., Pacetti, D., Vivarelli, M., Nicolini, D., et al. (2011) · Liver International

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 405

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice

De Minicis, S., Rychlicki, C., Agostinelli, L., Saccomanno, S., Candelaresi, C., Trozzi, L., Mingarelli, E., Facinelli, B., Magi, G., Palmieri, C., et al. (2014) · Hepatology

Gut microbiota and healthLiver physiology and pathology

Cited by 279

Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study

Giacchetti, G., Ronconi, V., Turchi, F., Agostinelli, L., Mantero, F., Rilli, S., & Boscaro, M. (2007) · Journal of Hypertension

Hormonal Regulation and HypertensionPotassium and Related Disorders

Cited by 196

HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH

De Minicis, S., Agostinelli, L., Rychlicki, C., Sorice, G. P., Saccomanno, S., Candelaresi, C., Giaccari, A., Trozzi, L., Pierantonelli, I., Mingarelli, E., et al. (2014) · PLoS ONE

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 97

Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD

Pierantonelli, I., Rychlicki, C., Agostinelli, L., Giordano, D. M., Gaggini, M., Fraumene, C., Saponaro, C., Manghina, V., Sartini, L., Mingarelli, E., et al. (2017) · Scientific Reports

Liver Disease Diagnosis and TreatmentGut microbiota and health

Cited by 82